Skip Navigation

Publicaciones covid-9

Resource Feedback

If you know about a problem with one of our resource records, we want to know about it!

Resource Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
URL https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00331-3/fulltext
(if you would like a response)
Verification Code:
CAPTCHA Image
Reload Image